Antioxidants · 2023 · 30 citations · 43 references
MedicineNeurologyNeuroscienceDementiaMolecular NeurobiologyMolecular NeuroscienceAlzheimer DiseaseInsulin ResistanceNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationNeuroprotection18F-fluorodeoxyglucose Positron Emission TomographyAlzheimer Disease NeuroimmunologyGlucose Metabolism ImagingImmunofluorescence AssaysImmunofluorescence ImagingImmunofluorescence StainingNeuroinflammation In Alzheimer DiseaseNlrp3 Inflammasome
The reduction of the cerebral glucose metabolism is closely related to the activation of the NOD-like receptor protein 3 (NLRP3) inflammasome in Alzheimer’s disease (AD); however, its underlying mechanism remains unclear. In this paper, 18F-flurodeoxyglucose positron emission tomography was used to trace cerebral glucose metabolism in vivo, along with Western blotting and immunofluorescence assays to examine the expression and distribution of associated proteins. Glucose and insulin tolerance tests were carried out to detect insulin resistance, and the Morris water maze was used to test the spatial learning and memory ability of the mice. The results show increased NLRP3 inflammasome activation, elevated insulin resistance, and decreased glucose metabolism in 3×Tg-AD mice. Inhibiting NLRP3 inflammasome activation using CY-09, a specific inhibitor for NLRP3, may restore cerebral glucose metabolism by increasing the expression and distribution of glucose transporters and enzymes and attenuating insulin resistance in AD mice. Moreover, CY-09 helps to improve AD pathology and relieve cognitive impairment in these mice. Although CY-09 has no significant effect on ferroptosis, it can effectively reduce fatty acid synthesis and lipid peroxidation. These findings provide new evidence for NLRP3 inflammasome as a therapeutic target for AD, suggesting that CY-09 may be a potential drug for the treatment of this disease.
43
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka, Markus P. Kummer, Andrea Stutz et al. · Nature · 2012 · 2.9K citations · Full text
NLRP3 inflammasome activation drives tau pathology
Christina Ising, Carmen Venegas, Shuangshuang Zhang et al. · Nature · 2019 · 1.5K citations · Full text
New mitochondrial DNA synthesis enables NLRP3 inflammasome activation
Zhenyu Zhong, Shuang Liang, Elsa Sánchez‐López et al. · Nature · 2018 · 1.2K citations